LI Long-yun, ZHOU Cai-chun, ZHANG Guo-chun. The Value of EGFR Mutation and Gene Amplification in Predicting Response to Gefitinib in NSCLC Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
Citation:
|
LI Long-yun, ZHOU Cai-chun, ZHANG Guo-chun. The Value of EGFR Mutation and Gene Amplification in Predicting Response to Gefitinib in NSCLC Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
|
LI Long-yun, ZHOU Cai-chun, ZHANG Guo-chun. The Value of EGFR Mutation and Gene Amplification in Predicting Response to Gefitinib in NSCLC Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
Citation:
|
LI Long-yun, ZHOU Cai-chun, ZHANG Guo-chun. The Value of EGFR Mutation and Gene Amplification in Predicting Response to Gefitinib in NSCLC Patients[J]. Journal of Evidence-Based Medicine, 2006, 6(1): 23-27. DOI: 10.3969/j.issn.1671-5144.2006.01.008
|